Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 522 clinical trials
Featured trial
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)

  • 222 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Pilot Study of a 3d Motion Device- Feasibility Assessment in Patients with Parkinson’s Disease and Friedreich’s Ataxia

Pilot Study of a 3d Motion Device- Feasibility Assessment in Patients with Parkinson’s Disease and Friedreich’s Ataxia

  • 160 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Parkinson's Disease Study

Parkinson's Disease Study

  • 320 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Open Label Parkinson's clinical research study

Open Label Parkinson's clinical research study

  • 716 views
  • 25 Mar, 2021
  • 1 location
Featured trial
An Open-Label Evaluation of the Safety and Tolerability of SAGE-718 in Participants with Parkinson’s Disease Mild Cognitive Impairment

Mild cognitive impairment is a condition that is associated with decreased quality of life, impaired functioning, and is common in people who have Parkinson’s Disease (PD). People with Parkinson’s Disease mild cognitive impairment (PD-MCI) are at a high risk for developing dementia.Your participation in this study will last approximately 7 weeks, including …

dementia
cognitive impairment
mild cognitive impairment
  • 0 views
  • 29 Jul, 2021
  • 2 locations
Featured trial
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

To examine the current disease progression of PDP, the clinical, economic, and humanistic impact of anti-psychotic therapy in the management of the condition in real-world settings, and the burden of the condition on patients and their caregivers

hallucinations
  • 1270 views
  • 16 Mar, 2020
  • 68 locations
Featured trial
FoxBioNet: ECV (Extracellular Vesicle) 004

The goal of this study is to identify reliable markers of LRRK2 activity in human CSF.

Accepts healthy volunteers
  • 0 views
  • 28 Apr, 2022
  • 3 locations
Objective, Passive Assessment of LRRK2 Carriers (OPAL)

This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …

Online studies
movement disorder
  • 8 views
  • 12 May, 2022
  • 1 location
  • Online study
Epidemiology and Pathophysiology of Parkinsonism in the Caribbeans

The primary aim of this study is to estimate the frequency and to characterize clinically atypical parkinsonism in the French West Indies and Guyana.

  • 0 views
  • 21 Jan, 2021
  • 2 locations
PDGeneration: Mapping the Future of Parkinson's Disease (PDGENE)

To assess the feasibility, impact, and participant satisfaction of offering Clinical Laboratory Improvement Amendments (CLIA) certified genetic testing as part of clinical care for People with Parkinson's disease (PWP).

  • 93 views
  • 16 Feb, 2022
  • 9 locations